GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35341
Submission : 2020-12-24
Status : Active
Type : IV
Certificate Number : R0-CEP 2023-020 - Rev 00
Issue Date : 2023-08-28
Type : Chemical
Substance Number : 892
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28408
Submission : 2014-06-16
Status : Active
Type : IV
Certificate Number : R1-CEP 2012-195 - Rev 01
Issue Date : 2019-11-22
Type : Chemical
Substance Number : 892
Status : Valid

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26093
Submission : 2012-04-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26094
Submission : 2012-04-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2855
Submission : 1977-02-08
Status : Active
Type : IV
Certificate Number : R1-CEP 2007-076 - Rev 01
Issue Date : 2015-06-26
Type : Chemical
Substance Number : 892
Status : Valid

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2297
Submission : 1974-06-14
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28972
Submission : 2014-12-29
Status : Active
Type : IV
Certificate Number : R1-CEP 2014-337 - Rev 00
Issue Date : 2020-11-13
Type : Chemical
Substance Number : 892
Status : Valid

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29000
Submission : 2015-01-08
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34076
Submission : 2019-09-11
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29013
Submission : 2015-01-22
Status : Active
Type : IV
Certificate Number : R1-CEP 2014-344 - Rev 00
Issue Date : 2021-02-05
Type : Chemical
Substance Number : 892
Status : Valid

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35341
Submission : 2020-12-24
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2297
Submission : 1974-06-14
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2855
Submission : 1977-02-08
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26094
Submission : 2012-04-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26093
Submission : 2012-04-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27357
Submission : 2013-04-23
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29312
Submission : 2015-04-10
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29013
Submission : 2015-01-22
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28408
Submission : 2014-06-16
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29000
Submission : 2015-01-08
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
EXCIPIENTS BY APPLICATIONS
Application : Disintegrants & Superdisintegrants
Excipient Details : Crospovidone is used as a disintegrant in solid oral dosage forms such as tablets and capsules.
Application : Disintegrants & Superdisintegrants
Excipient Details : Tablets, Granules, Pills, Disintegrants and fillers.
Brand Name : Microlex® Cr.PVD CL-110
Application : Disintegrants & Superdisintegrants
Excipient Details : It facilitates to facilitate the dissolution of poorly API due to porous surface morphology.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as Microlex® Cr.PVD CL-25, Microlex® Cr.PVD UCL-...
Ingredient(s) : Crospovidone
Application : Direct Compression
Excipient Details : Crospovidone is an insoluble polymer of N-vinyl-2-pyrrolidone that is used as a disintegrant in pharmaceutical tablets.
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for tablets.
Pharmacopoeia Ref : Ph.Eur., USP/NF and JP
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Application : Direct Compression
Excipient Details : Maximum disintegration
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Application : Direct Compression
Excipient Details : Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Application : Direct Compression
Excipient Details : Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.
Pharmacopoeia Ref : Ph. Eur., USP, JP: 90 % mannit...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Granule / Pellet, Orodispersible Tablet, Tablet
Grade : Not Available
Category : Direct Compression
Application : Direct Compression
Excipient Details : Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Granule / Pellet, Orodispersible Tablet, Tablet
Grade : Not Available
Category : Direct Compression
Application : Direct Compression
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
MARKET PLACE
Reply
16 Oct 2025
Reply
10 Jul 2025
Reply
21 Jan 2025
Reply
04 Jan 2025
Reply
27 Dec 2024
Reply
30 Sep 2024
Reply
10 Jun 2024
Reply
23 Nov 2023
Reply
29 May 2023
Reply
30 Mar 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES